Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data: An Initiative by the Korean Adrenal Disorder Study (KADS) Group

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This research aims to establish clinical evidence for optimal treatment guidelines for adrenal diseases using real-world data. The approach involves building prospective and retrospective patient registries, which will be utilized to develop and conduct research on disease-specific protocols for adrenal disorders. The study targets patients with primary aldosteronism, pheochromocytoma, adrenal cancer, adrenal incidentalomas, and mild autonomous cortisol secretion. Registries for patients with adrenal diseases will be obtained from Seoul National University Hospital and Asan Medical Center, along with securing a common data model. The ultimate goal is to conduct research to generate clinical evidence for adrenal diseases using these resources.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
View:

• patients with adrenal diseases such as adrenal cortical carcinoma, Cushing's syndrome, primary aldosteronism, pheochromocytoma, adrenal incidentaloma

• patients who are 19 years or older

Locations
Other Locations
Republic of Korea
Seoul National University Hospital
RECRUITING
Seoul
Contact Information
Primary
Jung Hee Kim, MD, PhD
jhee1@snu.ac.kr
+82-10-2072-4839
Time Frame
Start Date: 2022-05-10
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 8200
Treatments
Nonfunctioning adrenal adenoma
Incidentally detected adrenal mass without hormone production
Mild autonomous cortisol secretion
Adrenal tumors that do not meet the criteria for adrenal Cushing's syndrome but are not suppressed to below 1.8 µg/dL after the dexamethasone suppression test
Adrenal Cushing syndrome
Adrenal diseases characterized by biochemical hypercortisolism accompanying with overt Cushingoid features.
Primary aldosteronism
Adrenal diseases characterized by the excessive production of the hormone aldosterone and suppressed renin.~Diagnostic criteria are as the following:~1. Plasma aldosterone level of ≥6 ng/dL after a seated saline infusion test~2. Plasma aldosterone level of ≥13 ng/dL after a captopril challenge test.
Pheochromocytoma and paraganglioma
Chromaffin-originated tumors in the adrenal gland and others, characterized by catecholamine excess
Adrenal cortical carcinoma
Malignant tumors originated from the adrenal cortex, which was confirmed by biopsy or pathology results
Sponsors
Collaborators: Seoul National University Bundang Hospital, Samsung Medical Center, Asan Medical Center, Chonnam National University Hospital, Inha University Hospital, Nowon Eulji Medical Center
Leads: Seoul National University Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials